News
Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA data
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from customers using ancestry testing and other services.
Opinion
23andMe Re-Opens Data Auction With $305 Million Bid From Former CEO
After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy Wojcicki has started out hot with an opening bid nearly $50 million higher than the previous auction’s winner.
The fate of genetic data belonging to millions of 23andMe customers is again up in the air, as the bankrupt company seeks a ...
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...
The founder of 23andMe , Anne Wojcicki, has asked a U.S. judge to reopen an auction for the genetic testing company, saying ...
The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic ...
3dOpinion
There are standard solutions to the problem, but they are only partial solutions: In the past few months, I have written a ...
7don MSNOpinion
A key decision by the bankruptcy judge could help with protecting consumer data, write Diane Lourdes Dick and Anya Prince.
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback